Ellen Beausang's most recent trade in Aspira Women`s Health Inc was a trade of 4,843 Common Stock done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aspira Women`s Health Inc | Ellen Beausang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 4,843 | 6,458 (0%) | 0% | 0 | Common Stock | |
| Aspira Women`s Health Inc | Ellen Beausang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 4,843 | 0 | - | - | Restricted Stock Units | |
| Aspira Women`s Health Inc | Ellen Beausang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 1,615 | 1,615 (0%) | 0% | 0 | Common Stock | |
| Aspira Women`s Health Inc | Ellen Beausang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2025 | 1,615 | 4,843 | - | - | Restricted Stock Units | |
| Aspira Women`s Health Inc | Ellen Beausang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 6,458 | 6,458 | - | - | Restricted Stock Units |